GlassScriptPhysician profile
Steven W Braunstein
NPI 1821182494
$4,687.40
in general payments reported to CMS, 2019-2025
18 companies · $847 in 2025
The $847 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $307 · 2021: $217 · 2022: $791 · 2023: $595 · 2024: $1,545 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,987.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $2,064.02 | 2019-2025 | Idosetr, Idose, Istent Infinite |
| Bausch & Lomb Americas INC. | $645.22 | 2022-2025 | Envista Mx60 Iol, Vyzulta, Envista Aspire Iol |
| Alcon Vision LLC | $517.44 | 2022-2025 | Voyager Dslt, Clareon, Rocklatan |
| Sun Pharmaceutical Industries INC. | $306.35 | 2019-2024 | |
| Allergan, INC. | $156.87 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $138.38 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $134.92 | 2024 | Tecnis Simplicity, Tecnis Iol |
| Abbvie INC. | $133.01 | 2022 | |
| New World Medical,INC. | $132.61 | 2024 | Clearpath, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Tarsus Pharmaceuticals, INC. | $127.05 | 2024 | Xdemvy |
| Oyster Point Pharma, INC. | $118.47 | 2023 | Tyrvaya |
| Biotissue Holdings INC. | $82.78 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $41.89 | 2019-2021 | |
| Menicon America INC | $24.61 | 2020 | |
| Rayner Intraocular Lenses Limited | $19.89 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $17.00 | 2024 | Omni Surgical System |
| Novartis Pharmaceuticals Corporation | $14.89 | 2019 | |
| Kala Pharmaceuticals, INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Braunstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.